In this study, we first examined the expression of HMB45 in undifferentiated ADSCs because HMB45 is an antibody that recognizes a melanoma- and melanocyte-specific antigen [13, 14] that is expressed in amelanotic malignant melanoma [21]. The gene discussed is PMEL; the disease is melanoma.